New Medications

Resource Center

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

Featured

FDA Approval
doctor taking blood pressure
FDA Approval
FDA Approval Granted for Baxdrostat (Baxfendy) for Adults With Uncontrolled Hypertension
05/25/2026
Anthony Calabro, MA
The FDA approved Baxfendy as an adjunctive treatment to lower blood pressure in adults with hypertension not adequately controlled on other antihypertensive medications.
05/25/2026
FDA Alert
FDA logo on website
FDA Alert
FDA Approves Datopotamab Deruxtecan-dlnk (Datroway) for Unresectable or Metastatic Triple-Negative Breast Cancer
05/22/2026
Anthony Calabro, MA
On May 22, 2026, the FDA approved datopotamab deruxtecan-dlnk for adults with unresectable or metastatic triple-negative breast cancer who are not candidates for PD-1/PD-L1 inhibitor therapy, based on...
05/22/2026
FDA Alert
FDA website on computer screen
FDA Alert
FDA Approves Teclistamab Plus Daratumumab Hyaluronidase-fihj for Adults with Relapsed or Refractory Multiple Myeloma
03/06/2026
Kate Young
Based on findings from the phase 3 MajesTEC-3 trial, the FDA announced the approval of teclistamab (Tecvayli) plus daratumumab hyaluronidase-fihj for adults with relapsed or refractory multiple myeloma who...
03/06/2026

Interactive Features

Medication Prescribing
pharmacist with patient
Medication Prescribing
Pearls of Wisdom: What Medication Caused the Major Destabilization of INR?
08/13/2016
Joshua is an 80-year-old man who had been stable on coumadin for 12 months, consistently demonstrating an INR of 2.2 to 3.1. Today, Joshua presented with an INR of 21.4, which results in immediate admission...
08/13/2016
Oral and Perioral Lesions
oral ulcer
Oral and Perioral Lesions
Pearls of Wisdom: Aphthous Ulcers Part II
03/03/2016
We previously met Zeke, a 19-year-old college student with a history of recurrent aphthous ulcers.
03/03/2016
Pop Quiz
Woman holding neck in pain during a IgG4-RD flare.
Pop Quiz
How Could Inebilizumab Improve Outcomes for Patients With Immunoglobulin G4-Related Disease?
11/22/2015
Researchers recently investigated inebilizumab as a potential treatment option for patients with immunoglobulin G4-related disease. Test your understanding of the findings!
11/22/2015
Diabetes
statins
Diabetes
Pearls of Wisdom: Do Statins Cause Diabetes?
09/22/2014
We previously met Louis, a healthy 68-year-old male who currently takes no medications but has been reluctant to start statin use due to concerns that it may cause dementia. Today, you receive a call from...
09/22/2014

Clinical Insights

Gastroenterology
Gastroenterology
David Hudesman, MD, on Newer and Emerging Therapies for IBD
09/12/2020
In this 7-minute video, Dr Hudesman recaps his presentation on new and emerging therapeutic targets in IBD.
09/12/2020
Inflammatory Bowel Disease
Inflammatory Bowel Disease
David Rubin, MD, on New and Emerging Therapies for IBD
07/25/2020
David Rubin, MD, review his talk at the virtual AIBD 2020 regional meeting July 25 on new and emerging therapeutics for inflammatory bowel disease.
07/25/2020
NAFLD
NAFLD
Steven Grinspoon, MD, on Targeting Endocrine Pathways in NAFLD
07/15/2020
He discusses his session on endocrine pathways and therapeutic options for patients with nonalcoholic fatty liver disease, which he presented at Harvard University’s 21st Annual Symposium on NAFLD.
07/15/2020
new medications
new medications
Is It Finally Time to Consider a Polypill Approach to Cardiovascular Disease Risk Reduction?
03/08/2015
In this article Michael J. Bloch, MD, writes about the potential use of a polypill for cardiovascular disease prevention and discusses how the results of recent research supports the potential use in the...
03/08/2015